Filing Details
- Accession Number:
- 0000899243-19-010278
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-04-08 19:47:27
- Reporting Period:
- 2019-04-04
- Accepted Time:
- 2019-04-08 19:47:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1160308 | Savara Inc | SVRA | Pharmaceutical Preparations (2834) | 841318182 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1703641 | Taneli Jaakko Jouhikainen | 6836 Bee Cave Road, Building Iii Suite 200 Austin TX 78746 | President And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-04-04 | 7,815 | $9.00 | 184,754 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-04-05 | 849 | $9.00 | 183,905 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-04-08 | 16,336 | $9.04 | 167,569 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 31, 2018.
- The price is a weighted average sale price. The sale prices ranged from $9.00 to $9.17. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Billionaire Hedge Funds
